These findings lay the groundwork for future research aimed at unraveling the mechanistic underpinnings of CWF19L1-mediated immune modulation and exploring its therapeutic potential in immune-related disorders and cancer immunotherapies. The gene discussed is CWF19L1; the disease is cancer.